Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V By Means Of An Open House Model For Ws Lanthanum(Iii) Carbonate In The Dosage Form Of Chewable Tablets (Atc Code According To Who: V03Ae03)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 83127760

  Document Type - Tender Notices

Description - Description: The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 of the Social Code Book V for medicinal products containing the active ingredient lanthanum(III) carbonate in the form of chewable tablets (ATC code according to WHO: V03AE03). The contract is concluded within the framework of a so-called open house model, i.e. a contract is open to all interested pharmaceutical companies within the participation period, provided they meet and accept the participation requirements. This means that individual contract negotiations are not conducted and there is no (supply) exclusivity. It should be noted that the purc

Gt Ref Id - 83127760

Deadline - Jul 31, 2026